ECDC guideline for HIV indicator conditions14 | Operational definition |
---|---|
Sexually transmitted infections | Chlamydia, gonorrhoea, syphilis, hepatitis B, genital herpes, lymphogranuloma venereum, Condyloma acuminata and trichomoniasis |
Chlamydia | Chlamydia |
Gonorrhoea | Gonorrhoea |
Syphilis | Syphilis |
Hepatitis B | Hepatitis B |
Genital herpes | Genital herpes |
Lymphogranuloma venereum | Lymphogranuloma venereum |
Condyloma acuminata | Condyloma acuminata |
Trichomoniasis | Trichomoniasis |
Acute or chronic hepatitis A | Hepatitis A |
Acute or chronic hepatitis C | Hepatitis C |
Herpes zoster | Herpes zoster |
Severe or atypical psoriasis | Psoriasis |
Seborrhoeic dermatitis/exanthema | Seborrhoeic dermatitis |
Cervical dysplasia | Cervical dysplasia |
Community-acquired pneumonia | Pneumonia |
Unexplained oral candidiasis | Oral candidiasis |
Mononeuritis | Mononeuritis |
Peripheral neuropathy | Peripheral neuropathy |
Mononucleosis-like illness | Mononucleosis-like illness is defined as illness with at least two of these symptoms: rash, fever and swollen lymph glands, with or without muscle aches, sore throat and feeling sick |
Unexplained fever | Fever |
Unexplained weight loss | Weight loss |
Unexplained lymphadenopathy | Lymphadenopathy |
Unexplained chronic diarrhoea | Diarrhoea |
Unexplained leucocytopenia lasting >4 weeks | Leucocytopenia |
Unexplained thrombocytopenia lasting >4 weeks | Thrombocytopenia |
Unexplained chronic renal impairment | Chronic renal impairment |
ECDC, European Centre for Disease Prevention and Control.